美股A股
StockGist
Back
8-K2026-03-20· x-ai/grok-4.1-fast

QNCX · IRulya Therapeutics Inc.

0001193125-26-117794

SEC filing

Summary

Quince Therapeutics, Inc. received Nasdaq notices on March 16 and 17, 2026, for failing the Minimum Bid Price Requirement (below $1.00 for 30 consecutive business days) and MVLS Requirement (below $50,000,000 for 30 days). The Company has 180 calendar days until September 14, 2026, to regain compliance, with trading continuing uninterrupted on Nasdaq Global Select Market under QNCX.

Key takeaways